HomeTagsMoleculin Biotech

Moleculin Biotech

Biotechnology

Moleculin Announces Completion of Third SAD Cohort in Phase 1a Clinical Trial of WP1122

PR Newswire - August 22, 2022

Moleculin Biotech, Inc., a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, reported preliminary results...

Biotechnology

Moleculin Announces Completion of Second Single Ascending Dose Cohort in Phase 1a Clinical Trial

PR Newswire - July 11, 2022

Moleculin Biotech, Inc., a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, reported preliminary results...